68788-8744 : Major Nasal Decongestant .5 mg/ml Nasal Spray


NDC68788-8744
Labeler: Preferred Pharmaceuticals Inc.
Product Type: Human OTC Drug
Drug Name:  Major Nasal Decongestant
Dosage Form: Nasal Spray
Application #: M012
Rev. Date: 


NDC Package Codes:

  • 68788-8744-3: 1 BOTTLE, PUMP IN 1 CARTON (68788‑8744‑3) / 30 ML IN 1 BOTTLE, PUMP

Active Ingredients:

  • Oxymetazoline Hydrochloride

Dosage Strength:

  • .5 mg/mL

Pharmaceutical Classes:

  • Imidazolines [CS]
  • Increased Sympathetic Activity [PE]
  • Vasoconstriction [PE]
  • Vasoconstrictor [EPC]

Related Products:

Based on records with the same trade name.
  • 0904-7427 Major Nasal Decongestant .5 mg/ml Nasal Spray by Major Pharmaceuticals
  • 0904-7435 Major Nasal Decongestant .5 mg/ml Nasal Spray by Major Pharmaceuticals

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 68788-8744 QR Code

< Prev: 68788-8743Next: 68788-8745 >

Related Discussions:

Oxymetazoline nasal drops could not sleep
Recently bought Oxymetazoline nasal spray. I have COPD emphysema. I spent the whole night coughing with no sleep. Has an... 2 replies
oxymetazoline eye drops
I think they are selling Visine LR on the internet, but it is very expensive. It is the only gtts that work for me. Have... 2 replies
eye drops with oxymetazoline
replacement for Visine LR ## PLEASE IF THERE IS A REPLACEMENT FOR VLR, LET US KNOW ALL THE DETAILS OF THE EYE DROPS ASAP... 111 replies
Replacement for Visine L.R. w/oxymetazoline.
Opcon A eye drops work well for a short time. I haven't found any eye drops to replace Visine L.R. that have the las... 2 replies




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.